Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:05 PM
Ignite Modification Date:
2025-12-24 @ 2:05 PM
NCT ID:
NCT04310995
Eligibility Criteria:
Inclusion Criteria:
* Age≥18 years old，
* Male or female patients，
* Have signed informed consent，
* Have successfully received a RA-CABG surgery 1-3 days ago.
Exclusion Criteria:
* Previously experienced an allergy to active ingredients and/or excipients of experimental drugs,
* Hypotension (defined as systolic blood pressure \< 90mmHg or diastolic blood pressure \< 60mmHg) after surgery,
* Acute myocardial infarction, pulmonary congestion or cardiogenic shock after surgery,
* Concomitant medications with phosphodiesterase-5 inhibitors such as sildenafil, vardenafil, tadalafil, etc,
* Pathological sinus node syndrome, degree II or III atrioventricular block without cardiac pacemaker,
* With contraindications for coronary computed tomography angiography (CCTA) or coronary arteriography (CAG) examination, such as iodine allergy, etc. note: patients with renal insufficiency or even end-stage receiving hemodialysis but can be tolerated by CCTA or CAG examination (judged by investigators) are eligible for inclusion,
* History or evidence of ongoing alcohol or drug abuse,
* Life expectancy \< 1 year judged by investigators,
* Other inappropriate situations judged by investigators .
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04310995
Study Brief:
Protocol Section:
NCT04310995